Xencor’s $100 Million Collaboration Agreement with Johnson & Johnson

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Xencor on the deal.Xencor, a clinical-stage biopharmaceutical company, announced its $100 million collaboration agreement with Johnson & Johnson…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here